Countdown to HealthEquity (HQY) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Wall Street analysts project HealthEquity (HQY) to report Q2 earnings of $0.92 per share, a 7% year-over-year increase, on revenues of $318.81 million, up 6.3%. The consensus EPS estimate has remained stable over the past 30 days, indicating analyst confidence. Beyond top-line figures, key estimates include robust growth in Custodial Revenue (+11.9%) and Total HSA Assets reaching $32.48 billion, alongside an increase in total HSA accounts to 10.10 million, despite a slight anticipated decline in CDBs Accounts. This outlook comes as HQY shares have underperformed the S&P 500 over the last month, currently holding a Zacks Rank #3 (Hold).

Analysis

HealthEquity (HQY) is poised for steady top-line and bottom-line growth in its upcoming Q2 earnings release, with Wall Street analysts forecasting a 6.3% year-over-year revenue increase to $318.81 million and a 7% rise in EPS to $0.92. The stability of the consensus EPS estimate over the last 30 days suggests a firm analyst conviction in this outlook. A detailed look at the expected revenue composition reveals a significant divergence in performance across segments; robust growth is anticipated from Custodial Revenue, projected to climb 11.9% to $155.15 million, while Service Revenue is expected to contract by 0.6%. This highlights a critical dependence on custodial asset growth to drive overall results. Supporting this growth are strong underlying operating metrics, including an expected increase in Total HSA Assets to $32.48 billion and a rise in HSAs Accounts to 10.10 million. However, the stock's recent performance, a 6.7% decline over the past month in contrast to the S&P 500's gain, coupled with a Zacks Rank #3 (Hold), indicates that the market remains cautiously positioned ahead of the report, potentially having already priced in these moderate growth expectations.

Key Decisions for Investors

• Investors should scrutinize the reported revenue mix to confirm that the projected 11.9% growth in high-margin Custodial Revenue materializes to offset the anticipated weakness in Service Revenue, as this is the core driver of the current growth thesis.
• Pay close attention to the growth in key operational metrics, specifically the net increase in HSA accounts and total HSA assets, as these are leading indicators for future custodial and service revenue streams.
• Given the stock's recent underperformance and neutral 'Hold' rating, a position should be managed with caution, as the market may require a significant earnings beat and an upgraded outlook to reverse the negative price momentum.